Inhibition of Wnt and PI3K Signaling Modulates GSK-3β Activity and Induces Morphological Changes in Cortical Neurons: Role of Tau Phosphorylation

Glycogen synthase kinase GSK-3β has been identified as one of the major candidates mediating tau hyperphosphorylation at the same sites as those present in tau protein in brain from Alzheimer′s disease (AD) patients. However, the signal transduction pathways involved in the abnormal activation of GSK-3β, have not been completely elucidated. GSK-3β activity is repressed by the canonical Wnt signaling pathway, but it is also modulated through the PI3K/Akt route. Recent studies have suggested that Wnt signaling might be involved in the pathophysiology of AD. On the other hand, modulators of the PI3K pathway might be reduced during aging leading to a sustained activation of GSK-3β, which in turn would increase the risk of tau hyperphosphorylation. The role of Wnt and PI3K signaling inhibition on the extent of tau phosphorylation and neuronal morphology has not been completely elucidated. Thus, in the present investigation we analyzed the effects of different negative modulators of the Wnt and the PI3K pathways on GSK-3β activation and phosphorylation of tau at the PHF-1 epitope in cortical cultured neurons and hippocampal slices from adult rat brain. Changes in the microtubule network were also studied. We found that a variety of Wnt and PI3K inhibitors, significantly increased tau phosphorylation at the PHF-1 site, induced the disarrangement of the microtubule network and the accumulation of tau within cell bodies. These changes correlated with alterations in neuronal morphology.

[1]  S. Lovestone,et al.  The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. , 1997, Neuroscience.

[2]  H. Clevers,et al.  TCF transcription factors, mediators of Wnt-signaling in development and cancer. , 2002, Developmental biology.

[3]  Shao-Jun Tang,et al.  Activity-dependent Synaptic Wnt Release Regulates Hippocampal Long Term Potentiation* , 2006, Journal of Biological Chemistry.

[4]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[5]  Q. Tian,et al.  Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture , 2005, Journal of Neural Transmission.

[6]  K. Imahori,et al.  Glycogen synthase kinase 3β is identical to tau protein kinase I generating several epitopes of paired helical filaments , 1993 .

[7]  L. Massieu,et al.  Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons , 2005, Journal of neuroscience research.

[8]  T. Dale,et al.  Signal transduction by the Wnt family of ligands. , 1998, The Biochemical journal.

[9]  G. Terstappen,et al.  Inhibition of Wnt signaling, modulation of Tau phosphorylation and induction of neuronal cell death by DKK1 , 2006, Neurobiology of Disease.

[10]  D. Selkoe,et al.  Toward a Comprehensive Theory for Alzheimer's Disease. Hypothesis: Alzheimer's Disease Is Caused by the Cerebral Accumulation and Cytotoxicity of Amyloid β‐Protein , 2000, Annals of the New York Academy of Sciences.

[11]  Jesús Avila,et al.  Glycogen synthase kinase 3: a drug target for CNS therapies , 2004, Journal of neurochemistry.

[12]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[13]  J. Ávila,et al.  The inhibition of phosphatidylinositol‐3‐kinase induces neurite retraction and activates GSK3 , 2001, Journal of neurochemistry.

[14]  V. Budnik,et al.  Wnts: up-and-coming at the synapse , 2007, Trends in Neurosciences.

[15]  B. Agranoff,et al.  Wortmannin Blocks Goldfish Retinal Phosphatidylinositol 3-Kinase and Neurite Outgrowth , 1997, Neurochemical Research.

[16]  Tsuyoshi Miyaoka,et al.  Increased expression of Wnt-1 in schizophrenic brains , 1999, Schizophrenia Research.

[17]  C. Proud,et al.  Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. , 1994, The Biochemical journal.

[18]  H. Manji,et al.  The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS , 1999, Journal of neurochemistry.

[19]  L. Binder,et al.  Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.

[20]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[21]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[22]  S. R. Datta,et al.  Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway , 2001, Current Opinion in Neurobiology.

[23]  R. Nusse,et al.  β-catenin: a key mediator of Wnt signaling , 1998 .

[24]  D. Selkoe The genetics and molecular pathology of Alzheimer's disease: roles of amyloid and the presenilins. , 2000, Neurologic clinics.

[25]  N. Inestrosa,et al.  Protein kinase C inhibits amyloid β‐peptide neurotoxicity by acting on members of the Wnt pathway , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S Lovestone,et al.  Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormality , 1998, Neuroreport.

[28]  J. Wegiel,et al.  Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain. , 2001, Brain research. Brain research protocols.

[29]  N. Inestrosa,et al.  Wnt-3a overcomes β-amyloid toxicity in rat hippocampal neurons , 2004 .

[30]  A. Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. , 1998, The EMBO journal.

[31]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[32]  Akira Kikuchi,et al.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK‐3β and β‐catenin and promotes GSK‐3β‐dependent phosphorylation of β‐catenin , 1998 .

[33]  Andrew Tomlinson,et al.  arrow encodes an LDL-receptor-related protein essential for Wingless signalling , 2000, Nature.

[34]  A. Harwood,et al.  Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. , 2001, Biochemical and biophysical research communications.

[35]  K. Maiese,et al.  Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system. , 2004, Histology and histopathology.

[36]  James R. Woodgett,et al.  Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.

[37]  G. Brewer,et al.  Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combination , 1993, Journal of neuroscience research.

[38]  P. Salinas,et al.  WNT-7a induces axonal remodeling and increases synapsin I levels in cerebellar neurons. , 1997, Developmental biology.

[39]  Salinas Pc Wnt factors in axonal remodelling and synaptogenesis. , 1999 .

[40]  A. Hall,et al.  Axonal Remodeling and Synaptic Differentiation in the Cerebellum Is Regulated by WNT-7a Signaling , 2000, Cell.

[41]  A. Wynshaw-Boris,et al.  Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development , 2005, Nature Neuroscience.

[42]  A. Theibert,et al.  Functions of PI 3-kinase in development of the nervous system , 2002, International Journal of Developmental Neuroscience.

[43]  R. Jope,et al.  CREB DNA binding activity is inhibited by glycogen synthase kinase‐3β and facilitated by lithium , 2001, Journal of neurochemistry.

[44]  C. Arias,et al.  Okadaic Acid Induces Early Changes in Microtubule‐Associated Protein 2 and γ Phosphorylation Prior to Neurodegeneration in Cultured Cortical Neurons , 1993, Journal of neurochemistry.

[45]  Philip R. Cohen,et al.  Further evidence that the inhibition of glycogen synthase kinase‐3β by IGF‐1 is mediated by PDK1/PKB‐induced phosphorylation of Ser‐9 and not by dephosphorylation of Tyr‐216 , 1997, FEBS letters.

[46]  Marcela Colombres,et al.  Synaptotoxicity in Alzheimer's Disease: The Wnt Signaling Pathway as a Molecular Target , 2007, IUBMB life.

[47]  C. Arias,et al.  β‐Amyloid peptide fragment 25–35 potentiates the calcium‐dependent release of excitatory amino acids from depolarized hippocampal slices , 1995, Journal of neuroscience research.

[48]  S. Fukumoto,et al.  Akt Participation in the Wnt Signaling Pathway through Dishevelled* , 2001, The Journal of Biological Chemistry.

[49]  H. Manji,et al.  Molecular effects of lithium. , 2004, Molecular interventions.

[50]  E. Braak,et al.  Distribution, Levels, and Activity of Glycogen Synthase Kinase‐3 in the Alzheimer Disease Brain , 1997, Journal of neuropathology and experimental neurology.

[51]  Giancarlo V. De Ferrari and,et al.  Wnt signaling function in Alzheimer’s disease , 2000, Brain Research Reviews.

[52]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[53]  I. Grundke‐Iqbal,et al.  Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. , 2006, Journal of Alzheimer's disease : JAD.

[54]  K. Leroy,et al.  Increased level of active GSK‐3β in Alzheimer’s disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration , 2007, Neuropathology and applied neurobiology.

[55]  J. Ávila,et al.  Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. , 1999, FEBS letters.

[56]  K. Maiese,et al.  Vital elements of the Wnt-Frizzled signaling pathway in the nervous system. , 2005, Current neurovascular research.

[57]  E. Aronica,et al.  Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Associated with Neuronal Degeneration in Alzheimer's Brain , 2004, The Journal of Neuroscience.

[58]  G. Terstappen,et al.  Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells , 2006, Journal of neurochemistry.

[59]  M. Goedert,et al.  Glycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells , 1995, Neuroscience Letters.

[60]  S. Dedhar,et al.  Signaling through beta-catenin and Lef/Tcf. , 1999, Cellular and molecular life sciences : CMLS.

[61]  Philip Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001 .

[62]  H. Braak,et al.  A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads , 2004, Acta Neuropathologica.

[63]  Fred H. Gage,et al.  Wnt signalling regulates adult hippocampal neurogenesis , 2005, Nature.

[64]  W. Netzer,et al.  Overactivation of glycogen synthase kinase‐3 by inhibition of phosphoinositol‐3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory , 2003, Journal of neurochemistry.

[65]  C. Jomary,et al.  Secreted Frizzled-related proteins: searching for relationships and patterns. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[66]  R. Nicoll,et al.  Feed‐forward dendritic inhibition in rat hippocampal pyramidal cells studied in vitro , 1982, The Journal of physiology.

[67]  J. Ávila,et al.  Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration , 1999 .